Joyce Cenali Featured within Forbes.com
The day that many have waited for is finally here! Cannabis is now legal in Canada, making it the first major country (sorry Uruguay) to sell marijuana freely and without the threat of criminal prosecution. Yet, there’s another element that makes this milestone even more fraught with significance. A great deal of money is at stake. Top cannabis researchers ArcView Market Research in partnership with BDS Analytics estimate that the Canadian medical and recreational markets combined will pull in a total of $5.4 billion by 2022. Although that figure is not as high as say, ArcView/BDS Analytics’ $15.7 billion estimate for the U.S. adult-use market for 2022, how our friends in the Great White North handle its newly minted legal weed economy will serve as a litmus test for not only the entire world but the U.S. where the market remains fragmented due to the federal illegality.
